Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 13/04/17 → 13/04/21 |
Funding
- Pfizer, Inc.: $56,590.59
Keywords
- Biotechnology & Drug Development, Immunology
A PHASE 3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER
- Fling, John (PI)